×
About 5,070 results

ALLMedicine™ Glucose Intolerance Center

Research & Reviews  1,806 results

Effects of luseogliflozin on the secretion of islet hormones and incretins in patients ...
https://doi.org/10.1507/endocrj.EJ21-0696
Endocrine Journal; Bando S, Ichikawa R et. al.

Jan 25th, 2022 - The insufficient activity of insulin and the hyperactivity of glucagon are responsible for glucose intolerance in patients with type 2 diabetes. Whereas sodium-glucose cotransporter-2 (SGLT2) inhibitors improve blood glucose levels in patients wit...

Stevioside ameliorates hyperglycemia and glucose intolerance, in a diet-induced obese z...
https://doi.org/10.1016/j.orcp.2022.01.002
Obesity Research & Clinical Practice; Dandin E, Üstündağ ÜV et. al.

Jan 16th, 2022 - Obesity is an independent risk factor for type 2 diabetes and epigenetic regulatory mechanisms affect obesity-related mechanisms. Due to weight gain concern in society, artificial sweeteners with no nutritional value have been increasingly consume...

Arsenic exposure during pregnancy and postpartum maternal glucose tolerance: evidence f...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759206
Environmental Health : a Global Access Science Source; Fleisch AF, Mukherjee SK et. al.

Jan 16th, 2022 - Arsenic exposure has been associated with gestational diabetes mellitus. However, the extent to which arsenic exposure during pregnancy is associated with postpartum glucose intolerance is unknown. We studied 323 women in Bangladesh. We assessed a...

Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases ...
https://doi.org/10.1038/s41385-021-00477-5
Mucosal Immunology; Nagatake T, Kishino S et. al.

Jan 12th, 2022 - Dietary ω3 fatty acids have important health benefits and exert their potent bioactivity through conversion to lipid mediators. Here, we demonstrate that microbiota play an essential role in the body's use of dietary lipids for the control of infl...

Physiological predictors of cardiorespiratory fitness in children and adolescents with ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755930
Therapeutic Advances in Respiratory Disease; Burghard M, Takken T et. al.

Jan 12th, 2022 - [1] To investigate the cardiorespiratory fitness (CRF) levels in children and adolescents with cystic fibrosis (CF) with no ventilatory limitation (ventilatory reserve ⩾ 15%) during exercise, and [2] to assess which physiological factors are relat...

see more →

Guidelines  2 results

The polycystic ovary syndrome: a position statement from the European Society of Endocr...
https://doi.org/10.1530/EJE-14-0253
European Journal of Endocrinology; Conway G, Dewailly D et. al.

May 23rd, 2014 - Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The...

Consensus on infertility treatment related to polycystic ovary syndrome.
https://doi.org/10.1016/j.fertnstert.2007.09.041
Fertility and Sterility;

Feb 5th, 2008 - The treatment of infertile women with polycystic ovary syndrome (PCOS) is surrounded by many controversies. On the basis of the currently available evidence, a group of experts reached a consensus regarding the therapeutic challenges raised in the...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  96 results

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
https://clinicaltrials.gov/ct2/show/NCT04731272

Jan 11th, 2022 - Diabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced β-cell mass contributes to the insulin secretory defects that characterizes cystic fibrosis-related diabetes (CFR...

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
https://clinicaltrials.gov/ct2/show/NCT00455403

Dec 15th, 2021 - Metabolic syndrome is one of the most common disorders in industrialized countries. It consists of abnormal serum lipids, glucose intolerance, elevated blood pressure, and central obesity in the setting of insulin resistance. The syndrome substant...

Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
https://clinicaltrials.gov/ct2/show/NCT01375959

Dec 13th, 2021 - A. Introduction and Specific Aims Resveratrol (RSV), a plant-derived polyphenol and potential activator of the mammalian sirtuin, Sirt1, has demonstrated promising effects on insulin secretion, insulin sensitivity and glucose tolerance and has ext...

Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor
https://clinicaltrials.gov/ct2/show/NCT03512119

Nov 24th, 2021 - Cystic Fibrosis related diabetes (CFRD), a major factor of morbid-mortality in CF, is characterized by a preclinical phase of glucose intolerance particularly long reaching up to 10 years. At the physiopathology level, insulin secretion is determi...

Early Arthroscopic Partial Meniscectomy(APM)
https://clinicaltrials.gov/ct2/show/NCT05114694

Nov 10th, 2021 - Degenerate meniscus tears(DMTs) were the most common knee disease in aged and obese people. The most common treatment for DMTs was arthroscopic partial meniscectomy(APM) surgery and over half a million surgeries are performed annually in the USA. ...

see more →

News  121 results

Long-Term Toxicity With Frontline Steroids Remains a Key Consideration of Chronic GVHD Management
https://www.onclive.com/view/long-term-toxicity-with-frontline-steroids-remains-a-key-consideration-of-chronic-gvhd-management

Nov 19th, 2021 - Although steroids remain the frontline standard of care in chronic graft-vs-host disease (cGVHD), research into ways to augment their use and potentially replace them with more effective agents has become a significant area of interest, explained ...

Dr. Agarwal on Remaining Challenges With Abiraterone in mCSPC
https://www.onclive.com/view/dr-agarwal-on-remaining-challenges-with-abiraterone-in-mcspc

Oct 6th, 2021 - Neeraj Agarwal, MD, a professor of medicine and director of the Genitourinary Oncology Program at the Huntsman Cancer Institute, discusses remaining challenges with abiraterone acetate (Zytiga) in metastatic castration-sensitive prostate cancer (m...

Expert Discusses Degarelix and Other Developments in Prostate Cancer
https://www.onclive.com/view/expert-discusses-degarelix-and-other-developments-in-prostate-cancer

Oct 6th, 2021 - Guru Sonpavde, MD The question of when to administer the LHRH receptor antagonist degarelix (Firmagon) to patients with castration-sensitive prostate cancer versus an agonist still remains to be answered, according to Guru P. Sonpavde, MD. Unfor...

Time-Restricted Eating: An Easy Way to Improve Metabolic Health?
https://www.medscape.com/viewarticle/959770

Sep 27th, 2021 - Time-restricted eating — where caloric intake is restricted within a consistent interval of less than 12 hours without overtly attempting to reduce calories — has "generated impressive [animal] data in preventing or reversing metabolic diseases as...

Why Gestational Diabetes Follow-up Needs to Be Improved
https://www.medscape.com/viewarticle/957019

Aug 24th, 2021 - This transcript has been edited for clarity. Hello, my name is Kamlesh Khunti, professor of primary care, diabetes, and vascular medicine, and general practitioner in Leicester. Thank you for joining me for this session on gestational diabetes. Th...

see more →